# Biotage AB to acquire PhyNexus, Inc.

Biotage AB has agreed to acquire PhyNexus, Inc., a California-based company specializing in automated lab-scale purification technology for biomolecules. The acquisition aims to expand Biotage's separation business into new application areas.

- Type: Acquisition
- Announced: 2018-12-04
- Where: San Jose, California, United States
- Status: announced
- Products: automated lab-scale purification technology, Dual Flow Chromatography tip technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Biotage AB](https://endata.com/companies/19317.md) (acquirer)
- [PhyNexus, Inc.](https://endata.com/companies/19318.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/phynexus-inc-enters-into-an-agreement-to-be-acquired-by-biotage-ab-300760343.html), 2018-12-05: "The acquisition of PhyNexus is in line with our strategy to grow our separation business through expansion into new application areas."
- [biospace.com](https://www.biospace.com/phynexus-inc-enters-into-an-agreement-to-be-acquired-by-biotage-ab), 2018-12-05: "The acquisition of PhyNexus is in line with our strategy to grow our separation business through expansion into new application areas."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.